SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001078782-15-002094
Filing Date
2015-12-30
Accepted
2015-12-30 15:16:33
Documents
1
Period of Report
2015-04-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6769
  Complete submission text file 0001078782-15-002094.txt   8301
Mailing Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022
Business Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Issuer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 18 EAST 50TH STREET 5TH FLOOR NEW YORK NY 10022
Business Address 855-232-9953
Anastassov George (Reporting) CIK: 0001604392 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54296 | Film No.: 151313414